Improving the Design of CRISPR/Cas9 Knockout Assays
Award amount
$223,896Program and phase
STTR · Phase IAward year
2018Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Nawgen, LLC
- Proposal award date
- 2018-03-01
- Contract end date
- 2020-02-29
- UEI
- QYK8WGNJJ5T8
- Solicitation number
- PA17-303
- Topic code
- 400
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Rational design of small interfering RNA for genome-wide target knockdown
- New Assays for Expression Profiling of MicroRNAs
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Platform for Optimizing Yield and Quality of Therapeutic AAV Vector Manufacturing via Synthetic Helper Genes
- Ultra-low-temperature (6 K) static NMR-DNP for metalloproteins, proteins in cells, and materials
- Dynamical Diffraction Analysis for 3D Electron Crystallography
- Synthetic biology approaches for bio-orthogonal labeling of circular RNAs
- Break Wave lithotripsy to fragment large kidney stones
Research funding history
3 SBIR/STTR records share this UEI (2015–2018). Reported award amounts total $1,145,926. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services